BR100 Increased By (0.8%)
BR30 Increased By (0.66%)
KSE100 Increased By (0.75%)
KSE30 Increased By (0.78%)
AGHA 7.80 Increased By ▲ 0.05 (0.65%)
BECO 5.20 Increased By ▲ 0.01 (0.19%)
BML 57.93 Decreased By ▼ -0.73 (-1.24%)
BOP 34.25 Increased By ▲ 0.56 (1.66%)
CNERGY 10.95 Increased By ▲ 0.34 (3.2%)
CSIL 5.48 Increased By ▲ 0.18 (3.4%)
FCCL 54.62 Increased By ▲ 0.88 (1.64%)
FFL 16.67 Increased By ▲ 0.21 (1.28%)
FNEL 1.24 Increased By ▲ 0.02 (1.64%)
KEL 7.40 Increased By ▲ 0.12 (1.65%)
KOSM 5.76 Increased By ▲ 0.12 (2.13%)
LOTCHEM 29.84 Increased By ▲ 0.19 (0.64%)
MLCF 95.74 Decreased By ▼ -0.62 (-0.64%)
NBP 204.95 Increased By ▲ 1.42 (0.7%)
NCPL 57.90 Increased By ▲ 1.05 (1.85%)
NPL 69.10 Increased By ▲ 1.79 (2.66%)
OGDC 318.39 Increased By ▲ 0.17 (0.05%)
PACE 10.87 Increased By ▲ 0.24 (2.26%)
PAEL 42.95 Increased By ▲ 1.18 (2.82%)
PIBTL 16.82 Increased By ▲ 0.01 (0.06%)
PPL 221.60 Increased By ▲ 1.43 (0.65%)
PRL 52.10 Increased By ▲ 3.05 (6.22%)
PTC 71.30 Increased By ▲ 1.29 (1.84%)
SSGC 29.30 Increased By ▲ 0.16 (0.55%)
TBL 9.88 Increased By ▲ 0.11 (1.13%)
TELE 8.88 Increased By ▲ 0.06 (0.68%)
TPL 17.75 Increased By ▲ 0.58 (3.38%)
TPLP 12.88 Increased By ▲ 0.37 (2.96%)
TREET 22.81 Increased By ▲ 0.22 (0.97%)
TRG 60.04 Decreased By ▼ -0.18 (-0.3%)
By

AMSTERDAM: Dutch health technology company Philips on Wednesday said it expected fourth-quarter core profit to drop around 40% to about 650 million euros ($739.25 million), hit by a global shortage of electronic components and the fallout of a massive recall of ventilators.

Comparable sales fell 10% on a yearly basis to 4.9 billion euros, Philips said in its profit warning, due to the shortage of parts, a lack of freight capacity and customers postponing their orders.

Sales were around 350 million euros lower than Philips had expected, taking comparable sales over 2021 down 1% - while the company had guided for a small increase.

The supply-chain problems added to the worries over the recall of ventilators, for which Philips said it had taken a new provision of 225 million euros, as more devices needed to be repaired than previously expected.

Germany agrees new Covid curbs as Omicron variant spreads across globe

Philips last year set aside 500 million euros for the operation, as it estimated it would replace up to four million ventilators and respiratory devices worldwide because of a polyurethane foam part that might degrade and become toxic.

Philips shares have lost around a third of their value since the company announced the recall in April last year.

The company will publish full quarterly and yearly results on Jan. 24.

Comments

Comments are closed for this article.